Mak L - Search Results

1

Application of a deep learning algorithm for the diagnosis of HCC.

Yu PLH, Chiu KW, Lu J, Lui GCS, Zhou J, Cheng HM, Mao X, Wu J, Shen XP, Kwok KM, Kan WK, Ho YC, Chan HT, Xiao P, Mak LY, Tsui VWM, Hui C, Lam PM, Deng Z, Guo J, Ni L, Huang J, Yu S, Peng C, Li WK, Yuen MF, Seto WK. Yu PLH, et al. Among authors: mak ly. JHEP Rep. 2024 Sep 16;7(1):101219. doi: 10.1016/j.jhepr.2024.101219. eCollection 2025 Jan. JHEP Rep. 2024. PMID: 39687602 Free PMC article.

2

Investigational RNA Interference Agents for Hepatitis B.

Hui RW, Mak LY, Seto WK, Yuen MF. Hui RW, et al. Among authors: mak ly. BioDrugs. 2024 Dec 7. doi: 10.1007/s40259-024-00694-x. Online ahead of print. BioDrugs. 2024. PMID: 39644435

3

Gastrointestinal: Biliary Obstruction From Hepatic Artery Aneurysms: Implications for Treatment Selection.

Wong DN, Hui RW, Mak LY, Seto WK, Yuen MF. Wong DN, et al. Among authors: mak ly. J Gastroenterol Hepatol. 2024 Dec 4. doi: 10.1111/jgh.16841. Online ahead of print. J Gastroenterol Hepatol. 2024. PMID: 39632448 Review. No abstract available.

4

Multimodal multiphasic pre-operative image-based deep-learning predicts hepatocellular carcinoma outcomes after curative surgery.

Hui RW, Chiu KW, Lee IC, Wang C, Cheng HM, Lu J, Mao X, Yu S, Lam LK, Mak LY, Cheung TT, Chia NH, Cheung CC, Kan WK, Wong TC, Chan AC, Huang YH, Yuen MF, Yu PL, Seto WK. Hui RW, et al. Among authors: mak ly. Hepatology. 2024 Dec 2. doi: 10.1097/HEP.0000000000001180. Online ahead of print. Hepatology. 2024. PMID: 39626212

5

Bias in control selection associated with the use of rapid tests in influenza vaccine effectiveness studies.

Poukka E, Murphy C, Mak L, Cheng SMS, Peiris M, Tsang TK, Sullivan SG, Cowling BJ. Poukka E, et al. Among authors: mak l. medRxiv [Preprint]. 2024 Nov 18:2024.11.16.24317422. doi: 10.1101/2024.11.16.24317422. medRxiv. 2024. PMID: 39606339 Free PMC article. Preprint.

6

Mechanisms of HCC and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B.

Zhang S, Mak LY, Yuen MF, Seto WK. Zhang S, et al. Among authors: mak ly. Clin Mol Hepatol. 2024 Nov 21. doi: 10.3350/cmh.2024.0837. Online ahead of print. Clin Mol Hepatol. 2024. PMID: 39568126 Free article.

7

Prospect of emerging treatments for HBV functional cure.

Hui RW, Mak LY, Fung J, Seto WK, Yuen MF. Hui RW, et al. Among authors: mak ly. Clin Mol Hepatol. 2024 Nov 14. doi: 10.3350/cmh.2024.0855. Online ahead of print. Clin Mol Hepatol. 2024. PMID: 39541952 Free article. Review.

8

Reply to: "Community health strategies for chronic hepatitis B: Advancing care with the ALT/qHBsAg ratio".

Hui RW, Mak LY, Yuen MF. Hui RW, et al. Among authors: mak ly. J Hepatol. 2024 Nov 6:S0168-8278(24)02657-6. doi: 10.1016/j.jhep.2024.10.042. Online ahead of print. J Hepatol. 2024. PMID: 39515428 No abstract available.

9

Reply to: "Prediction of HBsAg loss after cessation of entecavir therapy".

Hui RW, Mak LY, Yuen MF. Hui RW, et al. Among authors: mak ly. J Hepatol. 2024 Nov 6:S0168-8278(24)02656-4. doi: 10.1016/j.jhep.2024.10.041. Online ahead of print. J Hepatol. 2024. PMID: 39515423 No abstract available.

10

Benefits of combining SGLT2 inhibitors and pioglitazone on risk of MASH in type 2 diabetes-A real-world study.

Lee CH, Lui DT, Mak LY, Fong CH, Chan KS, Mak JH, Cheung CY, Chow WS, Woo YC, Yuen MF, Seto WK, Lam KS. Lee CH, et al. Among authors: mak ly. Diabetes Obes Metab. 2024 Nov 5. doi: 10.1111/dom.16049. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 39497579

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

287 results

Search Page

Filters